AVXL
Anavex Life Sciences CorpNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$312.30M
P/E Ratio
—
EPS
$-0.46
Beta
1.18
52W High
$13.99
52W Low
$2.61
50-Day MA
$3.84
200-Day MA
$6.45
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
1.54
PEG Ratio
0.00
About Anavex Life Sciences Corp
Anavex Life Sciences Corp. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | -33.60% |
| Return on Assets | -21.60% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.37 |
| Price-to-Book | 2.41 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -5.54 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $92.67M |
| Float | $89.78M |
| % Insiders | 3.12% |
| % Institutions | 41.60% |
Analyst Ratings
Consensus ($22.00 target)
2
Buy1
HoldData last updated: 4/29/2026